Results 91 to 100 of about 4,977 (176)

Bridging the Gap: Infantile Hemangioma Care Variability Among Pediatric Care Physicians in Greece. [PDF]

Cureus
Alexopoulos A, Ntokos D, Kontara L, Malliarou M, Fradelos EC, Saridi M, Toska A, Sarafis P, Nasi L, Briana D.   +9 more
europepmc   +1 more source

Orphan drug propranolol for infantile hemangioma: ten-year real-world safety data from the FAERS database. [PDF]

Orphanet J Rare Dis
Li X, Zhao X, Yang C, Chen A.
europepmc   +1 more source

Exploring Nadolol as a Therapeutic Option for Infantile Hemangioma: A Narrative Review. [PDF]

Cureus
Chamoun G, Gutierrez JP, Sad do Valle R, Fure K, Forsyth A, Kanwal A, Choi H.   +6 more
europepmc   +1 more source

Topical propranolol for infantile hemangioma: a comprehensive review of mechanisms, clinical efficacy, and novel formulations. [PDF]

Front Pediatr
Chen F, Yang L, Li K, Chen J, Liu W, Ji Y, Xia M, Xie J, Ding K, Zeng Q, Hou F.   +10 more
europepmc   +1 more source

Factors influencing treatment duration of oral propranolol in infantile hemangioma: a five-year retrospective analysis. [PDF]

Front Pediatr
Li Q, Xiao L, Su M, Chen H, Zhang H, Cao N, Jiang L, Liu X, Zhang G.   +8 more
europepmc   +1 more source

A Systematic Review of the Efficacy and Safety of Sirolimus (Rapamycin) in the Management of Infantile Hemangioma. [PDF]

J Res Pharm Pract
Abtahi-Naeini B, Ahmadinia F, Ghorbali F, Foroughi E.   +3 more
europepmc   +1 more source

Case Report: Hepatic infantile hemangioma malignantly transformed into hemangiosarcoma. [PDF]

Front Oncol
Gu X, Tao Q, Lu Z, Liu J, Zhang Z, Lu C.
europepmc   +1 more source

Management of infantile hemangiomas

Journal of Cutaneous and Aesthetic Surgery, 2014
openaire   +2 more sources

RETRACTION: Our Experience With Propranolol for Infantile Hemangioma. [PDF]

Skin Res Technol
europepmc   +1 more source

Systemic angiogenic protein changes following propranolol therapy in infantile hemangioma: a multi-target perspective. [PDF]

Front Pharmacol
Liang L, Zhang Y, Ma Y, Liu J, Du W, Ma Q.   +5 more
europepmc   +1 more source